
Investors are diversifying bets in the healthcare sector, as they rush to develop treatments for Covid-19 has driven up prices for some pharmaceutical stocks. A record 48% of fund managers are overweight healthcare stocks, a BofA survey showed and the S&P 500 healthcare sector is up nearly 34% since its March low. Hopes for treatment مزید پڑھیں












Recent Comments